Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for instructions and the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | 166,753,206 | 160,545,802 | 176,855,692 | 138,798,417 | 150,881,176 | 793,834,293 |
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.... | 0 | |||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | 0 | |||||
| 4 | Total. Add lines 1 through 3 | 166,753,206 | 160,545,802 | 176,855,692 | 138,798,417 | 150,881,176 | 793,834,293 |
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f) .. | 12,425,761 | |||||
| 6 | Public support. Subtract line 5 from line 4. | 781,408,532 | |||||
Calendar year
(or fiscal year beginning in)
![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | 166,753,206 | 160,545,802 | 176,855,692 | 138,798,417 | 150,881,176 | 793,834,293 |
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | 5,160,349 | 4,322,033 | 6,807,160 | 9,621,065 | 6,721,516 | 32,632,123 |
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | 5,125 | 3,315 | 1,945 | 4,857 | 2,864 | 18,106 |
| 11 | Total support. Add lines 7 through 10 | 826,484,522 | |||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | ||||||
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | ||||||
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | ||||||
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | ||||||
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2018 | (b) 2019 | (c) 2020 | (d) 2021 | (e) 2022 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | ||||||
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | ||||||
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | ||||||
| 11 | Net income from unrelated business activities not included on line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | ||||||
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 0.015 of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by 0.035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | 1 | |
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
2 | |
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | 3 | |
| 4 Amounts paid to acquire exempt-use assets | 4 | |
| 5 Qualified set-aside amounts (prior IRS approval required - provide details in Part VI) | 5 | |
| 6 Other distributions (describe in Part VI). See instructions | 6 | |
| 7Total annual distributions. Add lines 1 through 6. | 7 | |
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
8 | |
| 9 Distributable amount for 2022 from Section C, line 6 | 9 | |
| 10 Line 8 amount divided by Line 9 amount | 10 | |
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2022 |
(iii) Distributable Amount for 2022 |
|
|---|---|---|---|---|
| 1 Distributable amount for 2022 from Section C, line 6 | ||||
|
2
Underdistributions, if any, for years prior to 2022 (reasonable cause required-- explain in Part VI).
See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2022: | ||||
| a From 2017....... | ||||
| b From 2018....... | ||||
| c From 2019....... | ||||
| d From 2020....... | ||||
| e From 2021....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2022 distributable amount | ||||
|
i
Carryover from 2017 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from line 3f. | ||||
| 4Distributions for 2022 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2022 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from line 4. | ||||
|
5
Remaining underdistributions for years prior to 2022, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2022. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2023. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2018..... | ||||
| b Excess from 2019..... | ||||
| c Excess from 2020..... | ||||
| d Excess from 2021..... | ||||
| e Excess from 2022..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|---|
| Schedule A, Part II, Line 10 Other Income | DESCRIPTION - OIL ROYALTIES, COLUMN A - 1545.0, COLUMN B - 1093.0, COLUMN C - 993.0, COLUMN D - 2851.0, COLUMN E - 1781.0, COLUMN F - 8263.0; DESCRIPTION - REVENUE SHARING-HOST VEHICLE CHARGING STATION, COLUMN A - 1278.0, COLUMN B - 1228.0, COLUMN C - 952.0, COLUMN D - 2006.0, COLUMN E - 1083.0, COLUMN F - 6547.0; DESCRIPTION - NET GIFT SHOP SALES, COLUMN A - 2302.0, COLUMN B - 994.0, COLUMN C - 0.0, COLUMN D - 0.0, COLUMN E - 0.0, COLUMN F - 3296.0; |
| Software ID: | 22016089 |
| Software Version: | 2022v5.0 |
Attach to Form 990 or 990-EZ.
Go to www.irs.gov/Form990 for the latest information.
| Return Reference | Explanation |
|---|---|
| Form 990, Part III, Line 4a continued1 | IMAGING REVEALS HOW LARGE HIV PROTEIN FUNCTIONS TO FORM INFECTIOUS VIRUS - UNDERSTANDING HOW HIV REPLICATES WITHIN CELLS IS KEY FOR DEVELOPING NEW THERAPIES FOR THE NEARLY 40 MILLION PEOPLE LIVING WITH HIV GLOBALLY. A TEAM OF SCIENTISTS FROM THE SALK INSTITUTE AND RUTGERS UNIVERSITY HAVE DETERMINED THE MOLECULAR STRUCTURE OF HIV POL, A PROTEIN THAT PLAYS A KEY ROLE IN THE LATE STAGES OF HIV REPLICATION, OR THE PROCESS THROUGH WHICH THE VIRUS PROPAGATES ITSELF AND SPREADS THROUGH THE BODY. DETERMINING THE MOLECULE'S STRUCTURE HELPS ANSWER LONGSTANDING QUESTIONS ABOUT HOW THE PROTEIN BREAKS ITSELF APART TO ADVANCE THE REPLICATION PROCESS. THE DISCOVERY REVEALS A NEW VULNERABILITY IN THE VIRUS THAT COULD BE TARGETED WITH DRUGS. THE STUDY WAS LED BY ASSISTANT PROFESSOR DMITRY LYUMKIS AND PUBLISHED IN SCIENCE ADVANCES ON JULY 6, 2022. THE BEST OFFENSE IS A GREAT DEFENSE FOR SOME CARNIVOROUS PLANTS - INSECT-EATING PLANTS HAVE FASCINATED BIOLOGISTS FOR MORE THAN A CENTURY, BUT HOW PLANTS EVOLVED THE ABILITY TO CAPTURE AND CONSUME LIVE PREY HAS LARGELY REMAINED A MYSTERY. NOW, SALK SCIENTISTS, ALONG WITH COLLABORATORS FROM WASHINGTON UNIVERSITY IN ST. LOUIS, HAVE INVESTIGATED THE MOLECULAR BASIS OF PLANT CARNIVORY AND FOUND EVIDENCE THAT IT EVOLVED FROM MECHANISMS PLANTS USE TO DEFEND THEMSELVES. THE RESEARCH DETAILS HOW CALCIUM MOLECULES MOVE DYNAMICALLY WITHIN CELLS IN THE LEAVES OF CARNIVOROUS PLANTS IN RESPONSE TO TOUCH FROM LIVE PREY. THE STUDY WAS LED BY PROFESSOR JOANNE CHORY AND PUBLISHED IN PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES ON JULY 11, 2022. HOW RNA PROCESSING GOES AWRY IN RARE IMMUNE DISEASE - RESEARCHERS AT THE SALK INSTITUTE AND KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (KAUST) IN SAUDI ARABIA DISCOVERED A NEW UNDERLYING CAUSE OF WISKOTT-ALDRICH SYNDROME, A RARE GENETIC DISEASE THAT LEADS TO BLEEDING AND IMMUNE DEFICIENCIES IN BABIES. THEY FOUND THE GENETIC MUTATIONS ASSOCIATED WITH WISKOTT-ALDRICH SYNDROME DISRUPT RNA SPLICING WHICH, IN TURN, PREVENTS NUMEROUS IMMUNE AND ANTI-INFLAMMATORY PROTEINS FROM BEING MADE CORRECTLY. THE STUDY WAS LED BY PROFESSOR JUAN CARLOS IZPISUA BELMONTE AND PUBLISHED IN NATURE COMMUNICATIONS ON JUNE 25, 2022. MAKING A MEMORY POSITIVE OR NEGATIVE - RESEARCHERS AT THE SALK INSTITUTE AND COLLEAGUES DISCOVERED THE MOLECULE IN THE BRAIN RESPONSIBLE FOR ASSOCIATING GOOD OR BAD FEELINGS WITH A MEMORY. THEIR DISCOVERY PAVES THE WAY FOR A BETTER UNDERSTANDING OF WHY SOME PEOPLE ARE MORE LIKELY TO RETAIN NEGATIVE EMOTIONS THAN POSITIVE ONES-AS CAN OCCUR WITH ANXIETY, DEPRESSION OR POST-TRAUMATIC STRESS DISORDER (PTSD). THE STUDY WAS LED BY PROFESSOR KAY TYE AND PUBLISHED IN NATURE ON JULY 20, 2022. A SURPRISING LINK BETWEEN MITOCHONDRIAL DNA AND INCREASED ATHEROSCLEROSIS RISK - MITOCHONDRIA ARE KNOWN AS CELLS' POWERHOUSES, BUT MOUNTING EVIDENCE SUGGESTS THEY ALSO PLAY A ROLE IN INFLAMMATION. SCIENTISTS FROM THE SALK INSTITUTE AND UC SAN DIEGO EXAMINED HUMAN BLOOD CELLS AND DISCOVERED A SURPRISING LINK BETWEEN MITOCHONDRIA, INFLAMMATION AND DNMT3A AND TET2-TWO GENES THAT NORMALLY HELP REGULATE BLOOD CELL GROWTH BUT, WHEN MUTATED, ARE ASSOCIATED WITH AN INCREASED RISK OF ARTERY-BLOCKING PLAQUE BUILDUP KNOWN AS ATHEROSCLEROSIS. THE FINDINGS COULD LEAD TO NEW THERAPEUTICS FOR ATHEROSCLEROSIS AND OTHER INFLAMMATORY DISEASES. THE STUDY WAS LED BY PROFESSOR GERALD SHADEL AND PUBLISHED IN IMMUNITY ON AUGUST 2, 2022. DISCOVERY ADVANCES THE POTENTIAL OF GENE THERAPY TO RESTORE HEARING LOSS - RESEARCH FROM THE SALK INSTITUTE AND THE UNIVERSITY OF SHEFFIELD MAY DRIVE THE DEVELOPMENT OF NEW GENE THERAPIES TO REPAIR HEARING LOSS. IN DEVELOPED COUNTRIES, ROUGHLY 80 PERCENT OF DEAFNESS CASES THAT OCCUR BEFORE A CHILD LEARNS TO SPEAK ARE DUE TO GENETIC FACTORS. ONE OF THESE GENETIC COMPONENTS LEADS TO THE ABSENCE OF THE PROTEIN EPS8, WHICH COINCIDES WITH IMPROPER DEVELOPMENT OF SENSORY HAIR CELLS IN THE INNER EAR. THE TEAM'S FINDINGS SHOW THAT DELIVERY OF NORMAL EPS8 CAN RESCUE STEREOCILIA ELONGATION AND THE FUNCTION OF AUDITORY HAIR CELLS IN THE EARS OF MICE AFFECTED BY THE LOSS OF EPS8. THE STUDY WAS LED BY ASSISTANT PROFESSOR URI MANOR AND PUBLISHED IN MOLECULAR THERAPY - METHODS & CLINICAL DEVELOPMENT ON JULY 31, 2022. NEW TARGET IDENTIFIED FOR TREATMENT OF PREMATURE AGING DISEASE - SCIENTISTS AT THE SALK INSTITUTE AND KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY (KAUST) IN SAUDI ARABIA DISCOVERED THAT A STRETCH OF DNA THAT HOPS AROUND THE HUMAN GENOME PLAYS A ROLE IN PREMATURE AGING DISORDERS. IN PEOPLE WITH EARLY AGING, OR PROGERIA, RNA ENCODED BY THIS MOBILE DNA BUILDS UP INSIDE CELLS. THE SCIENTISTS ALSO FOUND THAT BLOCKING THIS RNA REVERSES THE DISEASE IN MICE. THE STUDY WAS LED BY PROFESSOR JUAN CARLOS IZPISUA BELMONTE AND PUBLISHED IN SCIENCE TRANSLATIONAL MEDICINE ON AUGUST 10, 2022. HOW THE BRAIN GATHERS THREAT CUES AND TURNS THEM INTO FEAR - SCIENTISTS AT THE SALK INSTITUTE UNCOVERED A MOLECULAR PATHWAY THAT DISTILLS THREATENING SIGHTS, SOUNDS AND SMELLS INTO A SINGLE MESSAGE: BE AFRAID. A MOLECULE CALLED CGRP ENABLES NEURONS IN TWO SEPARATE AREAS OF THE BRAIN TO BUNDLE THREATENING SENSORY CUES INTO A UNIFIED SIGNAL, TAG IT AS NEGATIVE AND CONVEY IT TO THE AMYGDALA, WHICH TRANSLATES THE SIGNAL INTO FEAR. THE RESEARCH MAY LEAD TO NEW THERAPIES FOR FEAR-RELATED DISORDERS SUCH AS POST-TRAUMATIC STRESS DISORDER (PTSD) OR HYPERSENSITIVITY DISORDERS SUCH AS AUTISM, MIGRAINES AND FIBROMYALGIA. THE STUDY WAS LED BY ASSISTANT PROFESSOR SUNG HAN AND PUBLISHED IN CELL REPORTS ON AUGUST 16, 2022. HOW LIGHT AND TEMPERATURE WORK TOGETHER TO AFFECT PLANT GROWTH - PLANTS LENGTHEN AND BEND TO SECURE ACCESS TO SUNLIGHT. DESPITE OBSERVING THIS PHENOMENON FOR CENTURIES, SCIENTISTS DO NOT FULLY UNDERSTAND IT. SALK SCIENTISTS DISCOVERED THAT TWO PLANT FACTORS-THE PROTEIN PIF7 AND THE GROWTH HORMONE AUXIN-ARE THE TRIGGERS THAT ACCELERATE GROWTH WHEN PLANTS ARE SHADED BY CANOPY AND EXPOSED TO WARM TEMPERATURES AT THE SAME TIME. THE FINDINGS WILL HELP SCIENTISTS INCREASE CROP PRODUCTIVITY DESPITE RISING GLOBAL TEMPERATURES. THE STUDY WAS LED BY PROFESSOR JOANNE CHORY AND PUBLISHED IN NATURE COMMUNICATIONS ON AUGUST 29, 2022. BEYOND NEURONS: HOW CELLS CALLED ASTROCYTES CONTRIBUTE TO BRAIN DISORDERS - MOST RESEARCH ON BRAIN DISEASES FOCUSES ON NEURONS, BUT STAR-SHAPED CELLS CALLED ASTROCYTES, ANOTHER ABUNDANT CELL IN THE HUMAN BRAIN, MAY BEAR THE BRUNT OF THE RESPONSIBILITY IN SOME NEURODEVELOPMENTAL DISORDERS. SALK INSTITUTE SCIENTISTS IDENTIFIED A MOLECULE PRODUCED BY ASTROCYTES THAT INTERFERES WITH NORMAL NEURON DEVELOPMENT IN RETT, FRAGILE X AND DOWN SYNDROMES, AND REPORT THAT BLOCKING THE MOLECULE REDUCES THE SIGNS OF DISEASE IN MICE BRAINS. THE STUDY WAS LED BY ASSOCIATE PROFESSOR NICOLA ALLEN AND PUBLISHED IN NATURE NEUROSCIENCE ON AUGUST 30, 2022. AGGRESSION DE-ESCALATION GENE IDENTIFIED IN FRUIT FLIES - THE BRAIN MECHANISMS THAT CAUSE AGGRESSIVE BEHAVIOR HAVE BEEN WELL STUDIED, BTU FAR LESS IS KNOWN ABOUT THE PROCESSES THAT TELL THE BODY WHEN IT'S TIME TO STOP FIGHTING. SALK INSTITUTE SCIENTISTS IDENTIFIED A GENE AND A GROUP OF CELLS IN THE BRAIN THAT PLAY A CRITICAL ROLE IN SUPPRESSING AGGRESSION IN FRUIT FLIES. THE FINDINGS HAVE IMPLICATIONS FOR DISORDERS SUCH AS PARKINSON'S DISEASE, WHICH CAN SOMETIMES CAUSE BEHAVIORAL CHANGES LIKE INCREASED AGGRESSION AND COMBATIVENESS. THE STUDY WAS LED BY ASSOCIATE PROFESSOR KENTA ASAHINA AND PUBLISHED IN SCIENCE ADVANCES ON SEPTEMBER 7, 2022. TIME-RESTRICTED EATING IMPROVES HEALTH OF FIREFIGHTERS - FIREFIGHTER'S 24-HOUR SHIFTS ARE HARD ON THE BODY AND INCREASE THE RISK OF CARDIOMETABOLIC DISEASES, SUCH AS HEART DISEASE AND DIABETES, AS WELL AS CANCER. IN COLLABORATION WITH THE SAN DIEGO FIRE-RESCUE DEPARTMENT, SCIENTISTS FROM THE SALK INSTITUTE AND UC SAN DIEGO HEALTH CONDUCTED A CLINICAL TRIAL AND FOUND THAT TIME-RESTRICTED EATING IMPROVED MEASURES OF HEALTH AND WELLBEING IN FIREFIGHTERS. THE NEW FINDINGS MAY ALSO HAVE IMPLICATIONS FOR SHIFT WORKERS, SUCH AS MILITARY PERSONNEL; HEALTH CARE, FOOD SERVICE, AND TRANSPORTATION PROFESSIONALS; TELECOMMUNICATIONS STAFF; AND NEW PARENTS, WHOSE SCHEDULES OFTEN MIMIC SHIFT WORK WHEN CARING FOR A NEW BABY. THE STUDY WAS LED BY PROFESSOR SATCHIDANANDA PANDA AND PUBLISHED IN CELL METABOLISM ON OCTOBER 4, 2022. |
| Form 990, Part III, Line 4a continued2 | GROWING MOTOR NEURONS GUIDED BY "LOVE-HATE RELATIONSHIP" WITH BLOOD VESSELS - WHEN NEURONS INVOLVED IN MOVEMENT-CALLED MOTOR NEURONS-FORM, THEY MUST BUILD CONNECTIONS THAT REACH FROM THE BRAIN, BRAINSTEM, OR SPINAL CORD ALL THE WAY TO THE HEAD, ARMS, OR THE TIPS OF THE TOES. A COLLABORATIVE STUDY BETWEEN SALK INSTITUTE SCIENTISTS AND COLLEAGUES AT THE SAN RAFFAELE SCIENTIFIC INSTITUTE IN ITALY SHOWED HOW BLOOD VESSEL GENES PLAY A CRITICAL ROLE IN MOTOR NEURON DEVELOPMENT BY TELLING BLOOD VESSELS TO GET OUT OF THE WAY. THE DISCOVERY HAS IMPLICATIONS FOR UNDERSTANDING DISEASES IN WHICH MOTOR NEURON CONNECTIONS ARE DESTROYED, SUCH AS AMYOTROPHIC LATERAL SCLEROSIS (ALS) OR SPINAL MUSCULAR ATROPHY (SMA). THE STUDY WAS LED BY PROFESSOR SAMUEL PFAFF AND PUBLISHED IN NEURON ON OCTOBER 7, 2022. ANTI-INFLAMMATORY MOLECULES DECLINE IN THE AGING BRAIN - AGING INVOLVES INFLAMMATION, STRESS, METABOLISM CHANGES, AND MORE. A TEAM OF SALK INSTITUTE AND UC SAN DIEGO SCIENTISTS REVEALED ANOTHER FACTOR IMPLICATED IN THE AGING PROCESS-A CLASS OF LIPIDS CALLED SGDGS (3-SULFOGALACTOSYL DIACYLGLYCEROLS) THAT DECLINE IN THE BRAIN WITH AGE AND MAY HAVE ANTI-INFLAMMATORY EFFECTS. THE RESEARCH HELPS UNRAVEL THE MOLECULAR BASIS OF BRAIN AGING, REVEALS NEW MECHANISMS UNDERLYING AGE-RELATED NEUROLOGICAL DISEASES, AND OFFERS FUTURE OPPORTUNITIES FOR THERAPEUTIC INTERVENTION. THE STUDY WAS LED BY PROFESSOR ALAN SAGHATELIAN AND PUBLISHED IN NATURE CHEMICAL BIOLOGY ON OCTOBER 20, 2022. DETERIORATING NEURONS ARE SOURCE OF BRAIN INFLAMMATION IN ALZHEIMER'S DISEASE - SCIENTISTS FROM THE SALK INSTITUTE FOUND THAT NEURONS FROM PEOPLE WITH ALZHEIMER'S DISEASE SHOW DETERIORATION AND UNDERGO A LATE-LIFE STRESS PROCESS CALLED SENESCENCE. THESE NEURONS HAVE A LOSS OF FUNCTIONAL ACTIVITY, IMPAIRED METABOLISM, AND INCREASED BRAIN INFLAMMATION. THE RESEARCHERS ALSO DISCOVERED THAT TARGETING THE DETERIORATING NEURONS WITH THERAPEUTICS COULD BE AN EFFECTIVE STRATEGY FOR PREVENTING OR TREATING ALZHEIMER'S DISEASE. THE STUDY WAS LED BY PROFESSOR RUSTY GAGE AND PUBLISHED IN CELL STEM CELL ON DECEMBER 1, 2022. FLIPPING THE SWITCH: GENETIC CHANGES THAT TURN "ON" CANCER GENES - CANCER CAN BE CAUSED BY GENETIC MUTATIONS, YET THE IMPACT OF SPECIFIC TYPES SUCH AS STRUCTURAL VARIANTS THAT BREAK AND REJOIN DNA, CAN VARY WIDELY. RESEARCHERS FROM THE SALK INSTITUTE ZEROED IN ON SPECIFIC MECHANISMS THAT ACTIVATE ONCOGENES, SHOWING THAT THE ACTIVITY OF CANCER-ASSOCIATED MUTATIONS DEPENDS ON THE DISTANCE BETWEEN A PARTICULAR GENE AND THE SEQUENCES THAT REGULATE THE GENE, AS WELL AS ON THE LEVEL OF ACTIVITY OF THE REGULATORY SEQUENCES INVOLVED. THIS WORK ADVANCES THE ABILITY TO PREDICT AND INTERPRET WHICH GENETIC MUTATIONS FOUND IN CANCER GENOMES ARE CAUSING THE DISEASE. THE STUDY WAS LED BY ASSISTANT PROFESSOR JESSE DIXON AND PUBLISHED IN NATURE ON DECEMBER 7, 2022. NEW COMPOUND REVERSES GUT INFLAMMATION IN MICE - A DRUG DEVELOPED BY SALK INSTITUTE RESEARCHERS ACTS LIKE A MASTER RESET SWITCH IN THE INTESTINES. THE COMPOUND, CALLED FEXD, HAS PREVIOUSLY BEEN FOUND TO LOWER CHOLESTEROL, BURN FAT, AND WARD OFF COLORECTAL CANCER IN MICE. NOW, THE TEAM REPORTED THAT FEXD CAN ALSO PREVENT AND REVERSE INTESTINAL INFLAMMATION IN MOUSE MODELS OF INFLAMMATORY BOWEL DISEASE. THE STUDY WAS LED BY PROFESSOR RONALD EVANS AND PUBLISHED IN PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES ON DECEMBER 12, 2022. THE BRAIN'S ABILITY TO PERCEIVE SPACE EXPANDS LIKE THE UNIVERSE - SALK SCIENTISTS DISCOVERED THAT TIME SPENT EXPLORING AN ENVIRONMENT CAUSES NEURAL REPRESENTATIONS TO GROW IN SURPRISING WAYS. THEIR FINDINGS SHOW THAT NEURONS IN THE HIPPOCAMPUS ESSENTIAL FOR SPATIAL NAVIGATION, MEMORY, AND PLANNING REPRESENT SPACE IN A MANNER THAT CONFORMS TO A NONLINEAR HYPERBOLIC GEOMETRY-A THREE-DIMENSIONAL EXPANSE THAT GROWS OUTWARD EXPONENTIALLY. IN OTHER WORDS, IT'S SHAPED LIKE THE INTERIOR OF AN EXPANDING HOURGLASS. THE RESEARCHERS ALSO FOUND THAT THE SIZE OF THAT SPACE GROWS WITH TIME SPENT IN A PLACE. THIS DISCOVERY PROVIDES VALUABLE METHODS FOR ANALYZING DATA ON NEUROCOGNITIVE DISORDERS INVOLVING LEARNING AND MEMORY, SUCH AS ALZHEIMER'S DISEASE. THE STUDY WAS LED BY PROFESSOR TATYANA SHARPEE AND PUBLISHED IN NATURE NEUROSCIENCE ON DECEMBER 29, 2022. MICROPROTEIN INCREASES APPETITE IN MICE - OBESITY AND METABOLIC DISEASES, SUCH AS DIABETES, ARE EXTREMELY COMMON IN THE UNITED STATES. TINY PROTEINS CALLED MICROPROTEINS HAVE LONG BEEN OVERLOOKED IN RESEARCH, BUT NEW EVIDENCE DEMONSTRATES THAT THEY HAVE AN IMPORTANT ROLE IN METABOLISM. SALK INSTITUTE SCIENTISTS DISCOVERED THAT BOTH BROWN AND WHITE FAT IS FILLED WITH THOUSANDS OF PREVIOUSLY UNKNOWN MICROPROTEINS, AND SHOWED THAT ONE OF THESE MICROPROTEINS, CALLED GM8773, CAN INCREASE APPETITE IN MICE. THESE FINDINGS COULD LEAD TO THE DEVELOPMENT OF A THERAPEUTIC TO HELP PEOPLE GAIN WEIGHT IN CERTAIN DISEASE SITUATIONS, SUCH AS DURING CHEMOTHERAPY FOR CANCER. THE STUDY WAS LED BY PROFESSOR ALAN SAGHATELIAN AND PUBLISHED IN CELL METABOLISM ON JANUARY 3, 2023. TIME-RESTRICTED EATING RESHAPES GENE EXPRESSION THROUGHOUT THE BODY - EXACTLY HOW TIME-RESTRICTED FEEDING AFFECTS THE BODY ON THE MOLECULAR LEVEL, AND HOW THOSE CHANGES INTERACT ACROSS MULTIPLE ORGAN SYSTEMS, HAS NOT BEEN WELL UNDERSTOOD. SCIENTISTS AT THE SALK INSTITUTE SHOWED HOW TIME-RESTRICTED EATING INFLUENCES GENE EXPRESSION IN MICE ACROSS MORE THAN 22 REGIONS OF THE BODY AND BRAIN. THE FINDINGS HAVE IMPLICATIONS FOR A WIDE RANGE OF HEALTH CONDITIONS WHERE TIME-RESTRICTED EATING HAS SHOWN POTENTIAL BENEFITS, INCLUDING DIABETES, HEART DISEASE, HYPERTENSION, AND CANCER. THE STUDY WAS LED BY PROFESSOR SATCHIDANANDA PANDA AND PUBLISHED IN CELL METABOLISM ON JANUARY 3, 2023. SUPPLEMENTATION WITH AMINO ACID SERINE EASES NEUROPATHY IN DIABETIC MICE - APPROXIMATELY HALF OF PEOPLE WITH TYPE 1 OR TYPE 2 DIABETES EXPERIENCE PERIPHERAL NEUROPATHY-WEAKNESS, NUMBNESS, AND PAIN, PRIMARILY IN THE HANDS AND FEET. SALK INSTITUTE RESEARCHERS IDENTIFIED A NEW FACTOR CONTRIBUTING TO DIABETES-ASSOCIATED PERIPHERAL NEUROPATHY: ALTERED AMINO ACID METABOLISM. THE TEAM FOUND THAT DIABETIC MICE WITH LOW LEVELS OF TWO RELATED AMINO ACIDS, SERINE AND GLYCINE, ARE AT HIGHER RISK FOR PERIPHERAL NEUROPATHY. THEY WERE ALSO ABLE TO ALLEVIATE NEUROPATHY SYMPTOMS IN DIABETIC MICE BY SUPPLEMENTING THEIR DIETS WITH SERINE. THE STUDY WAS LED BY PROFESSOR CHRISTIAN METALLO AND PUBLISHED IN NATURE ON JANUARY 25, 2023. TELOMERES, MITOCHONDRIA, AND INFLAMMATION WORK TOGETHER TO PREVENT CANCER - A TEAM OF SALK SCIENTISTS DISCOVERED THAT WHEN TELOMERES, THE END CAPS OF OUR CHROMOSOMES, BECOME VERY SHORT, THEY COMMUNICATE WITH MITOCHONDRIA, THE CELL'S POWERHOUSES. THIS COMMUNICATION TRIGGERS A COMPLEX SET OF SIGNALING PATHWAYS AND INITIATES AN INFLAMMATORY RESPONSE THAT DESTROYS CELLS THAT COULD OTHERWISE BECOME CANCEROUS. THE FINDINGS OPEN NEW POSSIBILITIES FOR PREVENTING AND TREATING CANCER AND OTHER HARMFUL CONSEQUENCES OF AGING. THE STUDY WAS LED BY PROFESSORS JAN KARLSEDER AND GERALD SHADEL AND PUBLISHED IN NATURE ON FEBRUARY 8, 2023. AI CHATBOT CHATGPT MIRRORS ITS USERS TO APPEAR INTELLIGENT - THE ARTIFICIAL INTELLIGENCE (AI) LANGUAGE MODEL CHATGPT MAY HAVE MANY APPLICATIONS IN SCIENCE AND BUSINESS, BUT HOW MUCH DO THESE TOOLS UNDERSTAND WHAT WE SAY TO THEM AND HOW DO THEY DECIDE WHAT TO SAY BACK? SALK INSTITUTE SCIENTISTS EXPLORED THE RELATIONSHIP BETWEEN THE HUMAN INTERVIEWER AND LANGUAGE MODELS TO UNCOVER WHY CHATBOTS RESPOND IN PARTICULAR WAYS, WHY THOSE RESPONSES VARY, AND HOW TO IMPROVE THEM IN THE FUTURE. THE RESULTS SUGGEST THAT LANGUAGE MODELS REFLECT THE INTELLIGENCE AND DIVERSITY OF THEIR INTERVIEWER. THE STUDY WAS LED BY PROFESSOR TERRENCE SEJNOWSKI AND PUBLISHED IN NEURAL COMPUTATION ON FEBRUARY 17, 2023. NEW COMBINATION OF DRUGS WORKS TOGETHER TO REDUCE LUNG TUMORS IN MICE - STANDARD CHEMOTHERAPY AND IMMUNOTHERAPY TREATMENTS ARE NOT EFFECTIVE AGAINST NON-SMALL CELL LUNG CANCERS (NSCLCS) THAT HAVE AN LKB1 GENETIC MUTATION. A NEW STUDY REVEALED FDA-APPROVED TRAMETINIB AND ENTINOSTAT (WHICH IS CURRENTLY IN CLINICAL TRIALS) CAN BE GIVEN IN TANDEM TO PRODUCE FEWER AND SMALLER TUMORS IN MICE WITH LKB1-MUTATED NSCLC. THE STUDY WAS LED BY PROFESSOR REUBEN SHAW AND PUBLISHED IN SCIENCE ADVANCES ON MARCH 17, 2023. |
| Form 990, Part III, Line 4a continued3 | WEARABLE MICROSCOPES ADVANCE SPINAL CORD IMAGING IN MICE - WHILE THE SPINAL CORD IS KNOWN TO PLAY AN ESSENTIAL ROLE IN RELAYING PAIN SIGNALS, TECHNOLOGY HAS LIMITED SCIENTISTS' UNDERSTANDING OF HOW THIS PROCESS OCCURS ON A CELLULAR LEVEL. SALK SCIENTISTS CREATED WEARABLE MICROSCOPES TO ENABLE UNPRECEDENTED INSIGHT INTO THE SIGNALING PATTERNS THAT OCCUR WITHIN THE SPINAL CORDS OF MICE. THESE TECHNOLOGICAL ADVANCEMENTS WILL HELP RESEARCHERS BETTER UNDERSTAND THE NEURAL BASIS OF SENSATIONS AND MOVEMENT IN HEALTHY AND DISEASE CONTEXTS, SUCH AS CHRONIC PAIN, ITCH, AMYOTROPHIC LATERAL SCLEROSIS (ALS), OR MULTIPLE SCLEROSIS (MS). THE STUDIES WERE LED BY ASSOCIATE PROFESSOR AXEL NIMMERJAHN AND PUBLISHED IN NATURE COMMUNICATIONS ON MARCH 21, 2023, AND NATURE BIOTECHNOLOGY ON MARCH 6, 2023. NOT ALL ITCHES ARE THE SAME, ACCORDING TO THE BRAIN - RESEARCH BY SALK INSTITUTE SCIENTISTS REVEALED A DEDICATED BRAIN PATHWAY THAT DRIVES THE MECHANICAL SENSATION OF ITCH (E.G., THE SENSATION OF A MOSQUITO CRAWLING ON YOUR ARM) AND IS DISTINCT FROM THE NEURAL PATHWAY THAT ENCODES THE CHEMICAL SENSATION OF ITCH (E.G., FROM THE MOSQUITO'S SALIVA AFTER A BITE). THEY FOUND THAT A SMALL POPULATION OF NEURONS RELAYS MECHANICAL ITCH INFORMATION FROM THE SPINAL CORD TO THE BRAIN AND ALSO IDENTIFIED THE NEUROPEPTIDE SIGNALS THAT REGULATE BOTH ITCH TYPES. THE FINDINGS OPEN NEW AVENUES FOR THERAPEUTIC INTERVENTIONS FOR CHRONIC ITCH CONDITIONS, INCLUDING ATOPIC DERMATITIS AND PSORIASIS. THE STUDY WAS LED BY PROFESSOR MARTYN GOULDING AND ASSISTANT PROFESSOR SUNG HAN, AND PUBLISHED IN NEURON ON APRIL 5, 2023. MITOCHONDRIA POWER-SUPPLY FAILURE MAY CAUSE AGE-RELATED COGNITIVE IMPAIRMENT - RESEARCHERS AT THE SALK INSTITUTE FOUND THAT THE LOSS OF SYNAPSES BETWEEN NEURONS OCCURS WITH BOTH HEALTHY AND MEMORY-IMPAIRED AGING, BUT WHAT DIFFERS IS THE BREAKDOWN IN THE STANDARD CORRELATION BETWEEN THE SIZES OF SYNAPTIC BOUTONS AND THE MITOCHONDRIA INSIDE. THE FINDINGS HIGHLIGHT THIS VIOLATION OF THE ULTRASTRUCTURAL SIZE PRINCIPLE AND MITOCHONDRIA-RELATED FAILURES AS THE KEY TO AGE-RELATED COGNITIVE IMPAIRMENT, USHERING IN A NEW ERA FOR AGING RESEARCH. THE STUDY WAS LED BY PROFESSOR JOHN REYNOLDS AND PUBLISHED IN FRONTIERS IN AGING NEUROSCIENCE ON APRIL 12, 2023. CRACKING THE CASE OF MITOCHONDRIAL REPAIR AND REPLACEMENT IN METABOLIC STRESS - WHEN CELLULAR ENERGY LEVELS DIP, THE CELL RESPONSE TO THIS METABOLIC STRESS IS TO GET RID OF THE DAMAGED MITOCHONDRIA AND CREATE NEW ONES-BUT HOW THIS OCCURS REMAINED UNCLEAR. SCIENTISTS AT THE SALK INSTITUTE FOUND THAT A PROTEIN CALLED FNIP1 IS THE CRITICAL LINK BETWEEN A CELL SENSING LOW ENERGY LEVELS AND ELIMINATING AND REPLACING DAMAGED MITOCHONDRIA. THIS FUNDAMENTAL DISCOVERY CAN HELP US UNDERSTAND HEALTHY AGING, CANCEROUS TUMORS, NEURODEGENERATIVE DISEASES, AND MORE. THE STUDY WAS LED BY PROFESSOR REUBEN SHAW AND PUBLISHED IN SCIENCE ON APRIL 20, 2023. HOW AN AGGRESSION-PROMOTING BRAIN PEPTIDE WORKS IN FRUIT FLIES - SALK RESEARCHERS SHOWED HOW NEUROPEPTIDES RELEASED FROM A SMALL GROUP OF NEURONS CAN RESHAPE ACTIVITY PATTERNS IN MULTIPLE DOWNSTREAM BRAIN AREAS IN THE FLY AND IMPACT THE ANIMAL'S BEHAVIOR. THE FINDINGS ARE AN IMPORTANT STEP TO UNDERSTANDING HOW VARIABLE RESPONSES TO NEUROPEPTIDES CONTRIBUTE TO HUMAN CONDITIONS LIKE AUTISM-SPECTRUM DISORDER OR ATTENTION-DEFICIT DISORDERS. THE STUDY WAS LED BY ASSOCIATE PROFESSOR KENTA ASAHINA AND PUBLISHED IN THE JOURNAL OF NEUROSCIENCE ON MAY 10, 2023. A NEW MODEL OF STUDYING HUMAN BRAIN IMMUNE CELLS AND NEUROLOGICAL DISORDERS - UNLIKE SOME HUMAN CELLS THAT CAN BE STUDIED OUTSIDE OF THE BODY OR IN NONHUMAN MODELS, HUMAN MICROGLIA ARE DIFFICULT TO STUDY WHEN REMOVED FROM THE HUMAN-BRAIN-LIKE ENVIRONMENT. TO OVERCOME THIS BARRIER, SALK SCIENTISTS DEVELOPED AN ORGANOID MODEL THAT ALLOWS RESEARCHERS TO STUDY HUMAN MICROGLIAL DEVELOPMENT AND FUNCTION FOR THE FIRST TIME IN LIVING HUMAN-DERIVED TISSUE. THE SCIENTISTS ALSO EXAMINED PATIENT-DERIVED MICROGLIA FROM CHILDREN WITH MACROCEPHALIC AUTISM SPECTRUM DISORDER, HIGHLIGHTING THE IMPORTANCE OF IMMUNE CELL AND BRAIN INTERACTIONS IN NEURODEGENERATIVE AND DEVELOPMENTAL DISEASES. THE STUDY WAS LED BY PROFESSOR RUSTY GAGE AND PUBLISHED IN CELL ON MAY 11, 2023. SEEING THE INSIDES OF PLANTS IN 3D - SALK SCIENTISTS DEVELOPED A NEW TECHNOLOGY THAT CAN CAPTURE THE INTERNAL PLANT WORLD AT AN UNPRECEDENTED RESOLUTION, OPENING THE DOOR FOR UNDERSTANDING HOW PLANTS RESPOND TO A CHANGING CLIMATE. THE METHOD, CALLED PHYTOMAP, CAN CAPTURE ENTIRE PLANT TISSUES (LIKE THE WHOLE ROOT TIP), INSTEAD OF A SMALL SLICE, AND PROVIDES INSIGHT INTO THE COMPLEX BIOLOGICAL CONVERSATIONS BETWEEN CELLS THAT IS DIFFICULT IN TWO DIMENSIONS. THE STUDY WAS LED BY PROFESSOR JOSEPH ECKER AND PUBLISHED IN NATURE PLANTS ON JUNE 12, 2023. MAPPING THE DEVELOPMENT OF INFECTION-FIGHTING IMMUNE CELLS - SPECIALIZED IMMUNE CELLS, CALLED CYTOTOXIC T CELLS, CAN DEVELOP INTO SHORT-LIVED EFFECTOR CELLS THAT KILL INFECTED OR CANCEROUS CELLS WITHIN OUR BODIES. A SMALL PORTION OF THOSE EFFECTOR CELLS REMAIN AFTER AN INFECTION AND BECOME LONGER-LIVED MEMORY CELLS. SALK SCIENTISTS DISCOVERED THAT A PROTEIN COMPLEX CALLED CBAF CAN OPEN OR CLOSE GENETIC "DOORS" TO CONTROL WHETHER A T CELL BECOMES AN EFFECTOR OR A MEMORY CELL. THE FINDINGS ILLUMINATE HOW T CELLS FIGHT AND REMEMBER INFECTIONS AND PAVE THE WAY FOR THE DEVELOPMENT OF MORE EFFECTIVE VACCINES AND CANCER THERAPEUTICS. THE STUDY WAS LED BY PROFESSOR SUSAN KAECH AND ASSOCIATE PROFESSOR DIANA HARGREAVES, AND PUBLISHED IN IMMUNITY ON JUNE 13, 2023. ALL THE IMMUNITY, NONE OF THE SYMPTOMS - SALK SCIENTISTS DISCOVERED THAT, IN MICE, PAIRING DISEASE-CAUSING BACTERIA WITH SPECIFIC DIETARY INTERVENTIONS CREATES LONG-TERM IMMUNITY, REVEALING A NEW POTENTIAL VACCINATION STRATEGY FOR DIARRHEAL DISEASES LIKE E. COLI. THE STUDY WAS LED BY PROFESSOR JANELLE AYRES AND PUBLISHED IN SCIENCE ADVANCES ON JUNE 23, 2023. |
| Form 990, Part VI, Line 1a Delegate broad authority to a committee | THE EXECUTIVE COMMITTEE SHALL ADVISE AND AID THE OFFICERS OF THE CORPORATION IN ALL MATTERS CONCERNING ITS INTERESTS, INCLUDING WITHOUT LIMITATION ALL MATTERS RELATING TO COMPENSATION AND BENEFITS, AND SHALL POSSESS AND MAY EXERCISE, DURING THE INTERVALS BETWEEN THE MEETINGS OF THE BOARD OF TRUSTEES, ALL THE POWERS AND AUTHORITY OF THE BOARD OF TRUSTEES IN THE MANAGEMENT OF THE BUSINESS AND AFFAIRS OF THE CORPORATION, INCLUDING THE POWER TO AUTHORIZE THE CORPORATE SEAL TO BE AFFIXED TO ANY AND ALL DOCUMENTS WHICH MAY REQUIRE THE SAME TO BE AFFIXED THERETO, INSOFAR AS SUCH SEEMS TO THE EXECUTIVE COMMITTEE FOR THE BEST INTERESTS OF THE CORPORATION, IN ALL CASES IN WHICH SPECIFIC DIRECTIONS SHALL NOT HAVE BEEN GIVEN BY THE BOARD OF TRUSTEES, EXCEPT THAT THE EXECUTIVE COMMITTEE SHALL HAVE NO POWER TO ADOPT, AMEND, OR REPEAL THE BY-LAWS. |
| Form 990, Part VI, Line 6 Classes of members or stockholders | MEMBERSHIP OF THE CORPORATION CONSISTS OF THE PERSONS ELECTED TO THE BOARD OF TRUSTEES AND THREE MEMBERS FROM AMONG THE RESIDENT AND NON-RESIDENT FELLOWS AND PROFESSORS CHOSEN AND ELECTED ANNUALLY BY THE RESIDENT AND NON-RESIDENT FELLOWS AND PROFESSORS. |
| Form 990, Part VI, Line 7a Members or stockholders electing members of governing body | THE MEMBERS OF THE CORPORATION ELECT THE TRUSTEES. |
| Form 990, Part VI, Line 7b Decisions requiring approval by members or stockholders | THE MEMBERS OF THE CORPORATION MAY ALTER, AMEND, OR REPEAL THE BY-LAWS BY VOTE. |
| Form 990, Part VI, Line 11b Review of form 990 by governing body | THE FORM 990 IS PREPARED BY THE INSTITUTE, INTERNALLY REVIEWED BY THE CHIEF FINANCIAL OFFICER AND EXTERNALLY REVIEWED BY THE TAX DEPARTMENT OF A PUBLIC ACCOUNTING FIRM. PRIOR TO ELECTRONIC FILING, A COPY OF THIS FORM 990 IS PROVIDED TO AND DISCUSSED IN THE EXECUTIVE SESSION OF THE BOARD OF TRUSTEES. |
| Form 990, Part VI, Line 12c Conflict of interest policy | ANNUALLY, THE CONFLICT OF INTEREST DISCLOSURE STATEMENT IS SENT OUT FOR COMPLETION BY THE MEMBERS OF THE BOARD OF TRUSTEES, SENIOR MEMBERS OF ADMINISTRATION AND RESEARCHERS. THE DESIGNATED OFFICIAL FOR EACH GROUP REVIEWS THE COMPLETED FORMS AND BRINGS ANY POTENTIAL CONFLICT OF INTEREST TO THE RESPECTIVE COMMITTEES FOR REVIEW. UPON DETERMINATION THAT A CONFLICT OF INTEREST EXISTS, THE FOLLOWING CONDITIONS OR RESTRICTIONS MAY BE IMPOSED: A. MONITORING OF ACTIVITIES GENERATING THE CONFLICT BY ANOTHER MEMBER; B. DISQUALIFICATION FROM PARTICIPATION IN THE ACTIVITIES GIVING RISE TO THE CONFLICT; C. MODIFICATION OF RESPONSIBILITIES TO AVOID CONFLICTS; D. PUBLIC DISCLOSURE OR DIVESTITURE OF SIGNIFICANT FINANCIAL INTERESTS; E. MODIFICATION OF THE RESEARCH PLAN OR REMOVAL OF THE AFFECTED RESEARCHER FROM THE RESEARCH; F. SEVERANCE OF RELATIONSHIP THAT CREATES ACTUAL OR POTENTIAL CONFLICTS; G. TERMINATION OF EMPLOYMENT. |
| Form 990, Part VI, Line 15a Process to establish compensation of top management official | A COMPREHENSIVE MARKET ASSESSMENT WAS COMPLETED IN APRIL 2023 BASED ON DATA FROM A SELECTED PEER GROUP AND HISTORICAL OVERALL MARKET DATA FOR SALK PRESIDENT AND EXECUTIVE LEADERSHIP ROLES. THIS REPORT WAS PROVIDED TO THE CHAIR AND CO-CHAIRS OF SALK'S BOARD OF TRUSTEES AND TO SALK'S CURRENT PRESIDENT AND PREVIOUS PRESIDENT. SALK'S PRESIDENT FOR THE PERIOD THROUGH APRIL 2023 DISCUSSED THE PERFORMANCE OF EACH VICE-PRESIDENT LEVEL EXECUTIVE AT A SPECIAL MEETING HELD ON JUNE 13, 2023, WITH THE CHAIR AND CO-CHAIR OF THE BOARD OF DIRECTORS AND SALK'S CURRENT PRESIDENT. AFTER DISCUSSION, RECOMMENDED CHANGES WERE APPROVED FOR VICE-PRESIDENT LEVEL INCUMBENTS ON SALK'S EXECUTIVE LEADERSHIP TEAM. NO CHANGES WERE RECOMMENDED FOR THE SALK PRESIDENT ROLE DUE TO THE LIMITED TENURE OF THE INCUMBENT. ALL COMPENSATION CHANGES WERE EFFECTIVE JULY 1, 2023. |
| Form 990, Part VI, Line 15b Process to establish compensation of other employees | A COMPREHENSIVE MARKET ASSESSMENT WAS COMPLETED IN APRIL 2023 BASED ON DATA FROM A SELECTED PEER GROUP AND HISTORICAL OVERALL MARKET DATA FOR SALK PRESIDENT AND EXECUTIVE LEADERSHIP ROLES. THIS REPORT WAS PROVIDED TO THE CHAIR AND CO-CHAIRS OF SALK'S BOARD OF TRUSTEES AND TO SALK'S CURRENT PRESIDENT AND PREVIOUS PRESIDENT. SALK'S PRESIDENT FOR THE PERIOD THROUGH APRIL 2023 DISCUSSED THE PERFORMANCE OF EACH VICE-PRESIDENT LEVEL EXECUTIVE AT A SPECIAL MEETING HELD ON JUNE 13, 2023, WITH THE CHAIR AND CO-CHAIR OF THE BOARD OF DIRECTORS AND SALK'S CURRENT PRESIDENT. AFTER DISCUSSION, RECOMMENDED CHANGES WERE APPROVED FOR VICE-PRESIDENT LEVEL INCUMBENTS ON SALK'S EXECUTIVE LEADERSHIP TEAM. NO CHANGES WERE RECOMMENDED FOR THE SALK PRESIDENT ROLE DUE TO THE LIMITED TENURE OF THE INCUMBENT. ALL COMPENSATION CHANGES WERE EFFECTIVE JULY 1, 2023. |
| Form 990, Part VI, Line 19 Required documents available to the public | UPON REQUEST, THE OFFICE OF THE CHIEF FINANCIAL OFFICER MAKES AVAILABLE TO THE PUBLIC THE INSTITUTE'S GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY. FINANCIAL STATEMENTS ARE AVAILABLE ON THE SALK WEBSITE. |
| Form 990, Part VII, Section A DIRECTORS COMPENSATION | THE FOLLOWING INDIVIDUALS WERE COMPENSATED FOR THE FOLLOWING SERVICES AND NOT PAID AS TRUSTEES: FRED GAGE, PH.D. - PRESIDENT/PROFESSOR; REUBEN SHAW, PH.D. - PROFESSOR; MARTYN GOULDING, PH.D. - PROFESSOR; TATYANA SHARPEE, PH.D. - PROFESSOR. |
| Form 990, Part VIII, Line 11d Other Miscellaneous Revenue | A/R RECHARGE ALLOWANCE - Total Revenue: -269603, Related or Exempt Function Revenue: , Unrelated Business Revenue: , Revenue Excluded from Tax Under Sections 512, 513, or 514: -269603; |
| Form 990, Part XI, Line 9 Other changes in net assets or fund balances | POSTRETIREMENT BENEFIT CHANGES OTHER THAN NET PERIODIC BENEFIT COST - 726028; CHANGE IN VALUE OF DEFERRED GIFTS - -46590; ROUNDING - -2; |
| Software ID: | 22016089 |
| Software Version: | 2022v5.0 |